Multi-Omics Integration for the Design of Novel Therapies and the Identification of Novel Biomarkers

19Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

Abstract

Multi-omics is a cutting-edge approach that combines data from different biomolecular levels, such as DNA, RNA, proteins, metabolites, and epigenetic marks, to obtain a holistic view of how living systems work and interact. Multi-omics has been used for various purposes in biomedical research, such as identifying new diseases, discovering new drugs, personalizing treatments, and optimizing therapies. This review summarizes the latest progress and challenges of multi-omics for designing new treatments for human diseases, focusing on how to integrate and analyze multiple proteome data and examples of how to use multi-proteomics data to identify new drug targets. We also discussed the future directions and opportunities of multi-omics for developing innovative and effective therapies by deciphering proteome complexity.

Cite

CITATION STYLE

APA

Ivanisevic, T., & Sewduth, R. N. (2023, December 1). Multi-Omics Integration for the Design of Novel Therapies and the Identification of Novel Biomarkers. Proteomes. Multidisciplinary Digital Publishing Institute (MDPI). https://doi.org/10.3390/proteomes11040034

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free